References
  1. Marrouche NF, Dresing T, Bash D, Saad E, Balaban K, Pavia SV, et al. Circular mapping and ablation of the pulmonary veins for treatment of atrial fibrillation: Impact of different catheter technologies. J Am Coll Cardiol 2002; 40: 464– 474.
  2. Hachiya H, Hirao K, Takahashi A, Nagata Y, Suzuki K, Maeda S, et al. Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive pulmonary vein isolation. J Cardiovasc Electrophysiol 2007; 18: 392–398.
  3. Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, et al. Complete isolation of left atrium surrounding the pulmonary veins: New insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 2004; 110: 2090– 2096
  4. Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: Results from the AATAC multicenter randomized trial. Circulation 2016; 133: 1637–1644
  5. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bansch D. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018;378:417–427.
  6. Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter ablation versus medical therapy for atrial fibrillation. Circulation: Arrhythmia and Electrophysiology. 2019;12:e007414
  7. Sessions AJ, May HT, Crandall BG, Day JD, Cutler DO MJ, Groh CA, et al. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart disease. J Cardiovasc Electrophysiol 2023; 34
  8. Akihiko Nogami*; Takashi Kurita*; Haruhiko Abe; Kenji Ando; Toshiyuki Ishikawa; Katsuhiko Imai; Akihiko Usui; Kaoru Okishige; Kengo Kusano; Koichiro Kumagai; Masahiko Goya; Yoshinori Kobayashi; Akihiko Shimizu; Wataru Shimizu; Morio Shoda; Naokata Sumitomo; Yoshihiro Seo; Atsushi Takahashi; Hiroshi Tada; Shigeto Naito; Yuji Nakazato; Takashi Nishimura; Takashi Nitta; Shinichi Niwano; Nobuhisa Hagiwara; Yuji Murakawa; Teiichi Yamane; Takeshi Aiba; Koichi Inoue; Yuki Iwasaki; Yasuya Inden; Kikuya Uno; Michio Ogano; Masaomi Kimura; Shun-ichiro Sakamoto; Shingo Sasaki; Kazuhiro Satomi; Tsuyoshi Shiga; Tsugutoshi Suzuki; Yukio Sekiguchi; Kyoko Soejima; Masahiko Takagi; Masaomi Chinushi; Nobuhiro Nishi; Takashi Noda; Hitoshi Hachiya; Masataka Mitsuno; Takeshi Mitsuhashi; Yasushi Miyauchi; Aya Miyazaki; Tomoshige Morimoto; Hiro Yamasaki; Yoshifusa Aizawa; Tohru Ohe; Takeshi Kimura; Kazuo Tanemoto; Hiroyuki Tsutsui; Hideo Mitamura on behalf of the JCS/JHRS Joint Working Group. JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias. Circ J 2021; 85: 1692–1700
  9. Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: The hfa-peff diagnostic algorithm: A consensus recommendation from the heart failure association (hfa) of the european society of cardiology (esc). Eur J Heart Fail. 2020;22:391-412
  10. Ichijo S, Miyazaki S, Kusa S, Nakamura H, Hachiya H, Kajiyama T, et al. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure. Journal of Cardiology 2018; 72: 240–246
  11. Rolf S, Kircher S, Arya A et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol.2014;7:825-33.
  12. Prabhu S, Taylor AJ, Costello BT, et al. Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study. J Am Coll Cardiol 2017;70: 1949–61.